Deep sequencing for detailed analysis of TP53 mutations clonal evolution in chronic lymphocytic leukemia

MALČÍKOVÁ, Jitka, Kateřina STAŇO KOZUBÍK, Boris TICHÝ, Barbara KANTOROVÁ, Lenka RADOVÁ, Nikola TOM, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Vasileios BIKOS, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Martin TRBUŠEK. Deep sequencing for detailed analysis of TP53 mutations clonal evolution in chronic lymphocytic leukemia. In 1st International conference on new concepts in B-cell malignancies, Řecko. 2014.

Basic information

• Original name: Deep sequencing for detailed analysis of TP53 mutations clonal evolution in chronic lymphocytic leukemia
• Authors: MALČÍKOVÁ, Jitka, Kateřina STAŇO KOZUBÍK, Boris TICHÝ, Barbara KANTOROVÁ, Lenka RADOVÁ, Nikola TOM, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Vasileios BIKOS, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Martin TRBUŠEK.
• Edition: 1st International conference on new concepts in B-cell malignancies, Řecko, 2014.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30200 3.2 Clinical medicine
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology

Links

• ED1.1.00/02.0068, research and development project: Name: CEITEC - central european institute of technology
• NT13493, research and development project: Name: Molekulární charakterizace B buněčných receptorů a jejich vztah k evoluci genetických změn u chronické lymfocytární leukémie
• NT13519, research and development project: Name: Časná identifikace CLL pacientů s dosud nevyselektovanými mutacemi v proteinu p53
• 286154, interní kód MU: Name: SYLICA - Synergies of Life and Material Sciences to Create a New Future (Acronym: SYLICA)

Investor: European Union, Capacities

• 306242, interní kód MU: Name: NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)

Investor: European Union, Cooperation

• 7E13008, research and development project: Name: Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)

Investor: Ministry of Education, Youth and Sports of the CR